Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-20 Sale | 2022-07-21 4:08 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 1,084 | $10.62 | $11,512 | 29,916 (Direct) | View |
| 2021-08-31 Purchase | 2021-09-01 4:04 pm | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 2,000 | $17.34 | $34,680 | 17,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-02 Option Award | 2023-03-03 09:22 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 2,000 | $0 | 0 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 09:22 am | 2022-07-12 2031-07-11 | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 50,000 | $0 | 0 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-03 09:22 am | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 31,916 | $20 | 0 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 4:01 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 2,000 | $0 | 31,000 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-05 4:16 pm | N/A N/A | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 12,000 | $0 | 29,000 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-20 4:09 pm | 2022-07-12 2031-07-11 | OPIANT PHARMACEUTICALS INC. | OPNT | Ruth Matthew R. Chief Commercial Officer | 65,000 | $0 | 65,000 (Direct) | View |